H

Harmonex Neuroscience Research | Dothan, AL

Research site

(Unclaimed)

Location

408 Healthwest Drive, Dothan, Alabama, United States of America

Site insights

Top conditions

Top treatments

Lurasidone

SHP465

Rapastinel

SPN-812

Guanfacine HCl

Divalproex

Lithium

Balovaptan

Aripiprazole

Vilazodone

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

4 of 49 total trials

A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder (X-NOVA3)

X-NOVA3 is a Phase 3, multicenter, randomized, double-blind, placebo-controlled study to evaluate the clinical efficacy, safety, and tolerability of...

Enrolling

Major Depressive Disorder

Drug: Azetukalner

Drug: Placebo

ML-004 Open-Label Extension Study in Adults and Adolescents With Autism Spectrum Disorders (ASD)

ML-004-003 is a multi-center, open-label extension study that will enroll approximately 120 adolescent and adult subjects with ASD that have complete...

Invitation-only

Autism Spectrum Disorder

Drug: ML-004 (IR)/(ER) tablet

Locations recently updated

Multicenter Study of Lumateperone for the Treatment of Bipolar Depression in Pediatric Patients

This is a multicenter, randomized, double-blind, placebo-controlled study in pediatric patients who are experiencing major depressive episodes (MDEs)...

Enrolling

Bipolar Depression

Drug: Lumateperone

Drug: Placebo

Locations recently updated

Multicenter Study of Lumateperone for the Treatment of Irritability Associated With Autism Spectrum Disorder in Pediatric Patients

This is a multicenter, randomized, double-blind, placebo-controlled study in pediatric patients aged 5 to 17 years with a primary diagnosis of irrita...

Enrolling

Irritability Associated With Autism Spectrum Disorder

Drug: Lumateperone high dose

Drug: Lumateperone low dose